您现在的位置:首页 > 资料文献 > 肾脏

Nature Medicine: Inhibition of CBLB protects from lethal Candida albicans sepsis

作者:   发布于:2023年08月09日  点击量:1049
Title:

Inhibition of CBLB protects from lethal Candida albicans sepsis

Journal:

Nature Medicine

Year:2016
Abstract

Fungal infections claim an estimated 1.5 million lives each year. Mechanisms that protect from fungal infections are still elusive. Recognition of fungal pathogens relies on C-type lectin receptors (CLRs) and their downstream signaling kinase SYK. Here we report that the E3 ubiquitin ligase CBLB controls proximal CLR signaling in macrophages and dendritic cells. We show that CBLB associates with SYK and ubiquitinates SYK, dectin-1, and dectin-2 after fungal recognition. Functionally, CBLB deficiency results in increased inflammasome activation, enhanced reactive oxygen species production, and increased fungal killing. Genetic deletion of Cblbprotects mice from morbidity caused by cutaneous infection and markedly improves survival after a lethal systemic infection with Candida albicans. On the basis of these findings, we engineered a cell-permeable CBLB inhibitory peptide that protects mice from lethal C. albicans infections. We thus describe a key role for Cblb in the regulation of innate antifungal immunity and establish a novel paradigm for the treatment of fungal sepsis.



Cite

2332

NM-inhibition of CBLB-results







Links
https://www.nature.com/articles/nm.4134(如需全文,请联系我们)